Delivery Order SPE2DB20D3101-SPE2DB24FRNA5
Award Date
6/17/24
Potential Completion Date
6/18/24
Potential Value
$28K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FEEB7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,950.69 firm fixed-price delivery order is for the supply of 4567645535 ONDANSETRON HCL 8 MG TABLET 500S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and was awarded on March 20, 2025. This award is part of a larger Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,777.63, is for the supply of 4566582363 - ONDANSETRON HCL 8 MG TABLET 30S. The contract has a completion date of December 3, 2024 and a firm fixed price pricing type. Amerisourcebergen Drug Corp is the prime contractor for this award and holds a significant Indefinite...
This contract award with ID SPE2DB20D1110|SPE2DB25FK04B was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,543.27 Firm Fixed Price Delivery Order is for the supply of 4567694098 ONDANSETRON HCL 8 MG TABLET 30S. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4567795620 ONDANSETRON ODT 8 MG TABLET 30S. The contract has a ceiling value of $5,367.06 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 4, 2025. The contract does not have a set-aside designation, indicating it was open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,772.75, is a Delivery Order for the supply of 4567140054 - ONDANSETRON HCL 4 MG TABLET 30S. The contract has a period of performance through February 4, 2025 and uses a Firm Fixed Price pricing type. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp...
This federal contract award, valued at $59,423.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4566491380 ONDANSETRON HCL 4 MG TABLET 30S, with a completion date of November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award with ID SPE2DB20D1100|SPE2DB24FB5B1 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award, valued at $5,981.44, is for the delivery of 4564435295 ! ONDANSETRON ODT 4 MG TABLET 30S. The contract has a firm fixed price pricing type and an ultimate completion date of April 30, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FESA7, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564610456 - ONDANSETRON ODT 8 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $6,630.14 and an ultimate completion date of May 16, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $4,151.47, is a Firm Fixed Price Delivery Order for the supply of 4566572940 ! ONDANSETRON HCL 8 MG TABLET 30S. The ultimate completion date is December 2, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This federal contract award, with ID SPE2DB22D1106|SPE2DB24FESG7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,246.15 firm fixed-price delivery order is for the supply of 4564618150 - ONDANSETRON HCL 8 MG TABLET 30S, with a period of performance through May 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a significant...